• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

五种临床重要神经胶质蛋白在人脑的分布。

Distribution of five clinically important neuroglial proteins in the human brain.

机构信息

Department of Medical Sciences, Neurology, Uppsala University Hospital, 751 85, Uppsala, Sweden.

Department of Clinical Neurophysiology, Neurosurgery and Neurology, Uppsala University Hospital, 751 85, Uppsala, Sweden.

出版信息

Mol Brain. 2022 Jun 29;15(1):52. doi: 10.1186/s13041-022-00935-6.

DOI:10.1186/s13041-022-00935-6
PMID:35765081
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9241296/
Abstract

Glial fibrillary acidic protein (GFAP), myelin basic protein (MBP), neurofilament light chain (NFL), tau and ubiquitin carboxy-terminal hydrolase L1 (UCHL1) are five neuroglial proteins that are used as CSF or blood biomarkers of tissue damage in the nervous system. There is incomplete knowledge of how the concentration of these proteins differs between anatomical regions in the CNS as previous studies have focused on gene expression or non-quantitative protein analyses, limiting the interpretability of these biomarkers. The purpose of this study was to create a map of the tissue content of these proteins in different regions of the CNS. The concentrations of the investigated proteins were determined with ELISA in post mortem tissue homogenates from 17 selected anatomical regions in the CNS from ten deceased donors aged 24 to 50 years. When appropriate, the protein concentrations were adjusted for post-mortem interval. In total, 168 tissue samples were analysed. There was a substantial variation in the concentrations of GFAP, MBP, NFL, tau and UCHL1 between different CNS regions. Highly myelinated areas of the CNS had tenfold higher MBP concentration than cerebral cortex, whereas tau showed an inverse pattern. GFAP, NFL and tau displayed an anteroposterior gradient in cerebral white matter. The cerebellum had low concentrations of all the investigated proteins. In conclusion, the tissue concentrations of GFAP, MBP, NFL, tau and UCHL1 were determined throughout the CNS. This information can be used as a reference when interpreting circulating levels of these biomarkers in relation to the extent and localisation of CNS-damaging processes.

摘要

胶质纤维酸性蛋白(GFAP)、髓鞘碱性蛋白(MBP)、神经丝轻链(NFL)、tau 和泛素羧基末端水解酶 L1(UCHL1)是五种神经胶质蛋白,被用作 CSF 或血液中神经组织损伤的生物标志物。目前对于这些蛋白质在中枢神经系统(CNS)不同解剖区域的浓度差异知之甚少,因为之前的研究集中在基因表达或非定量蛋白质分析上,限制了这些生物标志物的可解释性。本研究旨在绘制这些蛋白质在 CNS 不同区域的组织含量图谱。使用 ELISA 法在 10 名 24 至 50 岁已故供体的 CNS 17 个选定解剖区域的死后组织匀浆中测定了所研究蛋白质的浓度,在适当情况下,根据死后间隔时间对蛋白质浓度进行了调整。总共分析了 168 个组织样本。GFAP、MBP、NFL、tau 和 UCHL1 的浓度在不同的 CNS 区域之间存在很大差异。CNS 中高度髓鞘化区域的 MBP 浓度比大脑皮层高 10 倍,而 tau 则呈现相反的模式。GFAP、NFL 和 tau 在大脑白质中表现出前后梯度。小脑所有研究蛋白的浓度均较低。总之,GFAP、MBP、NFL、tau 和 UCHL1 的组织浓度在整个 CNS 中均已确定。在解释与 CNS 损伤过程的范围和定位相关的这些生物标志物的循环水平时,这些信息可以用作参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3fb/9241296/f66b9ea32944/13041_2022_935_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3fb/9241296/f66b9ea32944/13041_2022_935_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3fb/9241296/f66b9ea32944/13041_2022_935_Fig1_HTML.jpg

相似文献

1
Distribution of five clinically important neuroglial proteins in the human brain.五种临床重要神经胶质蛋白在人脑的分布。
Mol Brain. 2022 Jun 29;15(1):52. doi: 10.1186/s13041-022-00935-6.
2
Plasma tau, NfL, GFAP and UCHL1 as candidate biomarkers of alcohol withdrawal-associated brain damage: A pilot study.血浆 tau、NfL、GFAP 和 UCHL1 作为与酒精戒断相关的脑损伤的候选生物标志物:一项初步研究。
Addict Biol. 2022 Nov;27(6):e13232. doi: 10.1111/adb.13232.
3
Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL.血浆神经丝轻链和胶质纤维酸性蛋白可预测 CADASIL 中的卒中。
J Neuroinflammation. 2020 Apr 22;17(1):124. doi: 10.1186/s12974-020-01813-5.
4
Plasma UCHL1, GFAP, Tau, and NfL Are Not Different in Young Healthy Persons With Mild COVID-19 Symptoms Early in the Pandemic: A Pilot Study.大流行早期有轻度新冠症状的年轻健康人群血浆中的泛素羧基末端水解酶L1、胶质纤维酸性蛋白、微管相关蛋白Tau和神经丝轻链无差异:一项初步研究
Neurotrauma Rep. 2023 May 15;4(1):330-341. doi: 10.1089/neur.2023.0014. eCollection 2023.
5
Plasma Markers of Neurodegeneration Are Raised in Friedreich's Ataxia.弗里德赖希共济失调患者的神经退行性变血浆标志物升高。
Front Cell Neurosci. 2018 Oct 30;12:366. doi: 10.3389/fncel.2018.00366. eCollection 2018.
6
Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancer.血清神经胶质纤维酸性蛋白是转移性乳腺癌患者脑转移的预测因子。
Int J Cancer. 2021 Oct 15;149(8):1605-1618. doi: 10.1002/ijc.33724. Epub 2021 Jul 19.
7
Hepatic and renal function impact concentrations of plasma biomarkers of neuropathology.肝脏和肾脏功能会影响神经病理学血浆生物标志物的浓度。
Alzheimers Dement (Amst). 2022 Jul 12;14(1):e12321. doi: 10.1002/dad2.12321. eCollection 2022.
8
Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3.Tau 和神经丝轻链作为脊髓小脑共济失调 3 型的液体生物标志物。
Eur J Neurol. 2022 Aug;29(8):2439-2452. doi: 10.1111/ene.15373. Epub 2022 May 26.
9
Brain-originated peptides as possible biochemical markers of traumatic brain injury in cerebrospinal fluid post-mortem examination.脑源性肽作为脑脊液死后检查中创伤性脑损伤可能的生化标志物。
Folia Neuropathol. 2018;56(2):97-103. doi: 10.5114/fn.2018.76613.
10
Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI.在亚急性和慢性创伤性脑损伤中,NfL、tau、GFAP 和 UCH-L1 的时间进程和诊断效用。
Neurology. 2020 Aug 11;95(6):e623-e636. doi: 10.1212/WNL.0000000000009985. Epub 2020 Jul 8.

引用本文的文献

1
Plasma Profiles of Neuroglial Injury Biomarkers after Ischemic Stroke.缺血性中风后神经胶质损伤生物标志物的血浆概况
Transl Stroke Res. 2025 Sep 3. doi: 10.1007/s12975-025-01380-y.
2
Extracellular Vesicle Glial Fibrillary Acidic Protein as a Circulating Biomarker of Traumatic Brain Injury Severity.细胞外囊泡胶质纤维酸性蛋白作为创伤性脑损伤严重程度的循环生物标志物
J Mol Neurosci. 2025 May 23;75(2):69. doi: 10.1007/s12031-025-02360-5.
3
Bilateral vestibulopathy in Alexander disease type II- a case report.II型亚历山大病中的双侧前庭病——病例报告

本文引用的文献

1
Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury.轴突标志物神经丝轻链预测创伤性脑损伤后的长期预后和进行性神经退行性变。
Sci Transl Med. 2021 Sep 29;13(613):eabg9922. doi: 10.1126/scitranslmed.abg9922.
2
The potential of serum neurofilament as biomarker for multiple sclerosis.血清神经丝作为多发性硬化症生物标志物的潜力。
Brain. 2021 Nov 29;144(10):2954-2963. doi: 10.1093/brain/awab241.
3
Serum Neurofilament Light Chain Measurement in MS: Hurdles to Clinical Translation.
Eur Arch Otorhinolaryngol. 2025 May 6. doi: 10.1007/s00405-025-09416-7.
4
The relevance of combined testing of cerebrospinal fluid glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 in multiple sclerosis and peripheral neuropathy.脑脊液胶质纤维酸性蛋白和泛素 C 末端水解酶 L1 联合检测在多发性硬化症和周围神经病变中的相关性
Neurol Sci. 2025 Mar;46(3):1301-1312. doi: 10.1007/s10072-024-07790-4. Epub 2024 Nov 20.
5
Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation.未接受口服抗凝治疗的心房颤动患者发生缺血性中风及其他心血管事件风险评估的神经胶质生物标志物
J Am Heart Assoc. 2025 Jan 21;14(2):e038860. doi: 10.1161/JAHA.124.038860. Epub 2025 Jan 22.
6
Case report: Antibodies to myelin basic protein in a podenco-crossbreed dog with seizures.病例报告:一只患有癫痫的波登可杂交犬体内存在抗髓鞘碱性蛋白抗体。
Front Vet Sci. 2024 Sep 30;11:1398694. doi: 10.3389/fvets.2024.1398694. eCollection 2024.
7
Dendrimers-Novel Therapeutic Approaches for Alzheimer's Disease.树枝状大分子——治疗阿尔茨海默病的新方法
Biomedicines. 2024 Aug 20;12(8):1899. doi: 10.3390/biomedicines12081899.
8
NfL concentration in CSF is a quantitative marker of the rate of neurodegeneration in aging and Huntington's disease: a semi-mechanistic model-based analysis.脑脊液中神经丝轻链(NfL)浓度是衰老和亨廷顿舞蹈病中神经退行性变速率的定量标志物:基于半机制模型的分析
Front Neurosci. 2024 Jul 3;18:1420198. doi: 10.3389/fnins.2024.1420198. eCollection 2024.
9
Granulocyte- Macrophage Colony-Stimulating Factor Reverses Immunosuppression Acutely Following a Traumatic Brain Injury and Hemorrhage Polytrauma in a Juvenile Male Rat Model.粒细胞-巨噬细胞集落刺激因子在幼年雄性大鼠创伤性脑损伤和出血性多发伤后急性逆转免疫抑制。
J Neurotrauma. 2024 Jul;41(13-14):e1708-e1718. doi: 10.1089/neu.2023.0169. Epub 2024 May 3.
10
Fabrication and Characterization of Quad-Component Bioinspired Hydrogels to Model Elevated Fibrin Levels in Central Nervous Tissue Scaffolds.用于模拟中枢神经组织支架中纤维蛋白水平升高的四组分仿生水凝胶的制备与表征
Gels. 2024 Mar 17;10(3):203. doi: 10.3390/gels10030203.
多发性硬化症中血清神经丝轻链的测量:临床转化面临的障碍。
Front Neurosci. 2021 Mar 25;15:654942. doi: 10.3389/fnins.2021.654942. eCollection 2021.
4
Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker.血清神经丝酸性蛋白:视神经脊髓炎谱系疾病生物标志物。
Ann Neurol. 2021 May;89(5):895-910. doi: 10.1002/ana.26067. Epub 2021 Mar 30.
5
Prediction of Outcome After Endovascular Embolectomy in Anterior Circulation Stroke Using Biomarkers.采用生物标志物预测前循环卒中血管内取栓术后的结局。
Transl Stroke Res. 2022 Feb;13(1):65-76. doi: 10.1007/s12975-021-00905-5. Epub 2021 Mar 15.
6
Proteomic Profiling of the Human Tissue and Biological Fluid Proteome.人类组织和生物体液蛋白质组的蛋白质组学分析。
J Proteome Res. 2021 Jan 1;20(1):444-452. doi: 10.1021/acs.jproteome.0c00502. Epub 2020 Oct 27.
7
Diagnosis of ischemic stroke using circulating levels of brain-specific proteins measured via high-sensitivity digital ELISA.使用高敏数字 ELISA 检测循环脑特异性蛋白水平诊断缺血性脑卒中。
Brain Res. 2020 Jul 15;1739:146861. doi: 10.1016/j.brainres.2020.146861. Epub 2020 Apr 27.
8
An atlas of the protein-coding genes in the human, pig, and mouse brain.人类、猪和鼠脑的蛋白质编码基因图谱。
Science. 2020 Mar 6;367(6482). doi: 10.1126/science.aay5947.
9
Interindividual and Regional Variability in Drug Transporter Abundance at the Human Blood-Brain Barrier Measured by Quantitative Targeted Proteomics.定量靶向蛋白质组学测量的人血脑屏障药物转运体丰度的个体间和区域变异性。
Clin Pharmacol Ther. 2019 Jul;106(1):228-237. doi: 10.1002/cpt.1373. Epub 2019 Mar 18.
10
Brain-originated peptides as possible biochemical markers of traumatic brain injury in cerebrospinal fluid post-mortem examination.脑源性肽作为脑脊液死后检查中创伤性脑损伤可能的生化标志物。
Folia Neuropathol. 2018;56(2):97-103. doi: 10.5114/fn.2018.76613.